Skip to content

Evaluation of the Effectiveness of Enhanced Recovery After Surgery (ERAS) Program in Pediatric Lung Surgery

Evaluation of the Effectiveness of Enhanced Recovery After Surgery (ERAS) Program in Pediatric Lung Surgery

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07241286
Enrollment
100
Registered
2025-11-21
Start date
2025-06-05
Completion date
2030-02-28
Last updated
2026-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enhanced Recovery After Surgery, ERAS, Lung Surgery, Pediatric

Keywords

Thoracoscopic, Partial resection, pediatric, infant, ERAS, VATS, lobectomy, segmentectomy

Brief summary

This study aims to evaluate the clinical effectiveness of the Enhanced Recovery After Surgery (ERAS) program for pediatric lung surgery at our institution.

Detailed description

Using a prospective cohort design, we will observe pediatric patients undergoing lung surgery following the implementation of the ERAS program as standard practice. Outcomes will be compared with a historical control group (2014-2023) to assess whether ERAS reduces hospital length of stay, lowers postoperative complication rates, accelerates recovery, and decreases healthcare costs.

Interventions

OTHEREnhanced Recovery After Surgery, ERAS

During the study period, all enrolled patients will be managed according to our institution's consensus checklist for pediatric lung surgery ERAS care. This includes ERAS education, preoperative assessment, fasting guidance, prophylaxis for nausea and vomiting, standardized anesthesia and surgical protocols, preference for minimally invasive surgery, multimodal postoperative analgesia, and encouragement of early oral intake and mobilization.

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children who underwent lung surgery at our hospital's Division of Pediatric Surgery

Exclusion criteria

* Patients who underwent multiple surgeries (including surgeries other than lung surgery) during the same hospitalization

Design outcomes

Primary

MeasureTime frameDescription
Length of hospital stayUp to 30 days after surgery.Number of days from index operation to hospital discharge

Secondary

MeasureTime frameDescription
Postoperative complicationsWithin 30 days after surgery.Incidence of postoperative complications, including prolonged air leak, pneumonia, surgical site infection, and other procedure-related events.
Duration of urinary catheter placementFrom date of surgery to catheter removal (up to 30 days)Number of days with indwelling urinary catheter postoperatively.
Duration of chest tube drainageFrom date of surgery to chest tube removal (up to 30 days).Number of days with thoracic drainage tube postoperatively.
Intensive care unit stayFrom date of ICU admission to transfer out (up to 30 days).Number of days in ICU after surgery.
Postoperative painDaily assessment up to 7 days postoperatively.Pain intensity assessed by numeric rating scale (NRS)
Postoperative analgesic useDaily assessment up to 7 days postoperatively.Total analgesic consumption.
30-day readmission or emergency department visitWithin 30 days post-discharge.Incidence of unplanned readmission or emergency department visit within 30 days after discharge.
Time to resumption of oral intakeFrom date of surgery to initiation of oral intake (up to 7 days).Interval from surgery to first tolerated oral feeding.
Hospital costFrom date of admission to discharge, up to 30 daysTotal hospitalization cost during the index admission.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 18, 2026